Colaxen Sp. z o.o. Company Profile - Poland | Financials & Key Executives

Colaxen Sp. z o.o. (Poland)

Main Activities: Toilet Preparation Manufacturing

Secondary Activities: Medical Equipment and Supplies Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Pharmacies and Drug Stores | Cosmetics, Beauty Supplies, and Perfume Stores | Electronic Shopping and Mail-Order Houses | Scientific Research and Development Services | Research and Development in Biotechnology (except Nanobiotechnology) | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Full name: Colaxen Sp. z o.o.

Profile Updated: November 22, 2023

Colaxen Sp. z o.o. is a company based in Poland, with its head office in Zielona Gora. The company operates in the Toilet Preparation Manufacturing industry. It was incorporated on August 23, 2019. There was a total negative growth of 69.83% in Colaxen Sp. z o.o.’s total assets over the same period.

Headquarters
Ul. Jana Z Kolna 12C/31
Zielona Gora; Lubuskie; Postal Code: 65-014

Contact Details: Purchase the Colaxen Sp. z o.o. report to view the information.

Basic Information

Outstanding Shares:

Purchase the Colaxen Sp. z o.o. report to view the information.

Registered Capital:

Purchase the Colaxen Sp. z o.o. report to view the information.

Incorporation Date:

August 23, 2019

Key Executives

Company Performance

Financial values in the chart are available after Colaxen Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Operating profit (EBIT)

95.32%▲

Net Profit (Loss) for the Period

95.32%▲

Total assets

-69.83%▼

Total equity

-69.83%▼

Return on Equity (ROE)

13.67%▲